BRCA1 and breast carcinoma: Despite the limitation of having only five BRCA1 mutant cell lines available in CCLE breast cancer panel, we found that these BRCA1-mutant cell lines, out of 43, exhibited significantly lower DepMap scores compared to BRCA1 wild-type cell lines.